Literature DB >> 17613716

Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy.

Fujio Umehara1, Hirohisa Nose, Mineki Saito, Michinari Fukuda, Mieko Ogino, Tomoko Toyota, Tomoaki Yuhi, Kimiyoshi Arimura, Mitsuhiro Osame.   

Abstract

This study investigated the role of human T-cell lymphotropic virus type I HTLV-I infection in 11 patients who developed slowly progressive myelopathy with abnormal spinal cord lesions. The authors performed clinical and neuroradiological examinations and calculated the odds that an HTLV-I-infected individual of a specific genotype, age, and provirus load has HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Anti-HTLV-I antibodies were present in both the serum and cerebrospinal fluid in all of the patients. Abnormal magnetic resonance imaging (MRI) lesions were classified as cervical to thoracic type (CT type), cervical type (C type), and thoracic type (T type). In each type, there was swelling of the spinal cords with high-intensity lesions, which were located mainly in bilateral posterior columns, posterior horns, or lateral columns. Virological and immunological analyses revealed that all patients showed a high risk of developing HAM/TSP. These 11 patients may have developed HAM/TSP, as manifested by spinal cord abnormalities shown on MRI. These MRIs implicate clinical variability of HAM/TSP, which may indicate active-early stages of HAM/TSP lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613716     DOI: 10.1080/13550280701258431

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  18 in total

1.  Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.

Authors:  M Nagai; K Usuku; W Matsumoto; D Kodama; N Takenouchi; T Moritoyo; S Hashiguchi; M Ichinose; C R Bangham; S Izumo; M Osame
Journal:  J Neurovirol       Date:  1998-12       Impact factor: 2.643

2.  Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.

Authors:  Hirohisa Nose; Mineki Saito; Koichiro Usuku; Amir H Sabouri; Toshio Matsuzaki; Ryuji Kubota; Nobutaka Eiraku; Yoshitaka Furukawa; Shuji Izumo; Kimiyoshi Arimura; Mitsuhiro Osame
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

3.  Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease.

Authors:  M C Levin; T J Lehky; A N Flerlage; D Katz; D W Kingma; E S Jaffe; J D Heiss; N Patronas; H F McFarland; S Jacobson
Journal:  N Engl J Med       Date:  1997-03-20       Impact factor: 91.245

4.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

5.  HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.

Authors:  K J Jeffery; K Usuku; S E Hall; W Matsumoto; G P Taylor; J Procter; M Bunce; G S Ogg; K I Welsh; J N Weber; A L Lloyd; M A Nowak; M Nagai; D Kodama; S Izumo; M Osame; C R Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

6.  The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.

Authors:  K J Jeffery; A A Siddiqui; M Bunce; A L Lloyd; A M Vine; A D Witkover; S Izumo; K Usuku; K I Welsh; M Osame; C R Bangham
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

7.  Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  Alison M Vine; Aviva D Witkover; Alun L Lloyd; Katie J M Jeffery; Asna Siddiqui; Sara E F Marshall; Mike Bunce; Nobutaka Eiraku; Shuji Izumo; Koichiro Usuku; Mitsuhiro Osame; Charles R M Bangham
Journal:  J Infect Dis       Date:  2002-09-13       Impact factor: 5.226

8.  Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP).

Authors:  Y Iwasaki
Journal:  J Neurol Sci       Date:  1990-04       Impact factor: 3.181

9.  Spinal Magnetic Resonance Image alterations in human T-lymphotropic virus type I-associated myelopathy patients before and after immunomodulating treatments.

Authors:  Yasutaka Tajima; Ri-ichiro Kishimoto; Kazumasa Sudoh; Yusei Miyazaki; Seiji Kikuchi; Kunio Tashiro
Journal:  J Neurol       Date:  2003-06       Impact factor: 4.849

10.  Chronic progressive cervical myelopathy with HTLV-I infection: Variant form of HAM/TSP?

Authors:  F Umehara; S Nagatomo; K Yoshishige; M Saito; Y Furukawa; K Usuku; M Osame
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

View more
  10 in total

1.  Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports.

Authors:  Silvia R Delgado; William A Sheremata; Andrew D Brown; Micheline McCarthy
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

2.  HTLV-I-associated myelopathy/tropical spastic paraparesis: semiautomatic quantification of spinal cord atrophy from 3-dimensional MR images.

Authors:  Iordanis E Evangelou; Raya Massoud; Steven Jacobson
Journal:  J Neuroimaging       Date:  2012-02-03       Impact factor: 2.486

Review 3.  Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica.

Authors:  Corinna Trebst; Peter Raab; Elke Verena Voss; Paulus Rommer; Mazen Abu-Mugheisib; Uwe K Zettl; Martin Stangel
Journal:  Nat Rev Neurol       Date:  2011-11-01       Impact factor: 42.937

Review 4.  Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis: a systematic review.

Authors:  Ana Patrícia Bastos Ferreira; Ana Dolores Firmino Santos do Nascimento; Pedro Augusto Sampaio Rocha-Filho
Journal:  J Neurovirol       Date:  2022-01-03       Impact factor: 2.643

Review 5.  COVID-19-Associated Myelitis Involving the Dorsal and Lateral White Matter Tracts: A Case Series and Review of the Literature.

Authors:  H Y Huang; L M Shah; J S McNally; T Sant; T A Hutchins; E D Goldstein; M E Peckham
Journal:  AJNR Am J Neuroradiol       Date:  2021-08-19       Impact factor: 4.966

Review 6.  [HTLV-1-associated myelopathy/tropical spastic paraparesis: a differential diagnosis in multiple sclerosis].

Authors:  A Liesz; S Hähnel; K Korn; M Esiri; W Hacke; B Wildemann
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

7.  Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Carlos Vilchez; Massiel Gonzalez-Reinoso; Caroline Cubbison; Eddy Perez-Then; Pedro Roa; Adriano Martínez; Bernd Foerster; Jairo Oviedo; Peter Stoeter
Journal:  J Neurovirol       Date:  2014-09-17       Impact factor: 2.643

8.  Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  Yoshihisa Yamano; Tomoo Sato
Journal:  Front Microbiol       Date:  2012-11-09       Impact factor: 5.640

9.  Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon.

Authors:  Massanobu Takatani; Myuki Esashika Crispim; Nelson Fraiji; Mariane Martins Araujo Stefani; Dagmar Kiesslich
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-03       Impact factor: 1.846

10.  Vestibular-evoked myogenic potential triggered by galvanic vestibular stimulation may reveal subclinical alterations in human T-cell lymphotropic virus type 1-associated myelopathy.

Authors:  Ludimila Labanca; Júlia Fonseca de Morais Caporali; Sirley Alves da Silva Carvalho; José Roberto Lambertucci; Anna Bárbara de Freitas Carneiro Proietti; Luiz Cláudio Ferreira Romanelli; Paul Avan; Fabrice Giraudet; Bárbara Oliveira Souza; Kyonis Rodrigues Florentino; Denise Utsch Gonçalves
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.